SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-049056
Filing Date
2019-02-25
Accepted
2019-02-25 08:15:34
Documents
10
Period of Report
2019-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d711608d8k.htm 8-K 47113
2 EX-3.1 d711608dex31.htm EX-3.1 58043
3 EX-10.1 d711608dex101.htm EX-10.1 687055
4 EX-10.2 d711608dex102.htm EX-10.2 114311
5 GRAPHIC g711608dsp65a.jpg GRAPHIC 6731
6 GRAPHIC g711608dsp65b.jpg GRAPHIC 8522
7 GRAPHIC g711608dsp66.jpg GRAPHIC 7549
8 GRAPHIC g711608dsp77.jpg GRAPHIC 8898
9 GRAPHIC g711608dsp78.jpg GRAPHIC 7200
10 GRAPHIC g711608dsp79.jpg GRAPHIC 10957
  Complete submission text file 0001193125-19-049056.txt   977974
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 19628120
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences